In contrast, it remains to be determined whether other predictive markers of severe dengue, such as chymase level (Tissera et al., 2017) and IgG antibody subtype (Wang et al., 2017) or level (Katzelnick et al., 2017), work in such heterogeneous patient populations. This evidence concerns the gene CMA1 and dengue disease.